ReviewJournal of anesthesia, analgesia and critical care2026
Transesophageal echocardiography in cardiac arrest: why, how, when, and where in clinical practice.
Review in Journal of anesthesia, analgesia and critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Real-time transesophageal echocardiography for guiding prolonged cardiopulmonary resuscitation.World journal of emergency medicine · 2026Article
- Extracorporeal Membrane Oxygenation in Refractory Cardiac Arrest: Current Evidence, Clinical Pathways and Future Directions.Life (Basel, Switzerland) · 2026Review
- Transesophageal echocardiography during cardiac arrest: integrating emerging prehospital evidence with practical boundaries for clinical application.Journal of anesthesia, analgesia and critical care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transesophageal echocardiography (TEE) has emerged as a transformative tool in the management of cardiac arrest, offering significant advantages over traditional transthoracic echocardiography (TTE) by enabling continuous, high-resolution cardiac imaging during resuscitation. Initially used in operating rooms before 2000, TEE expanded into emergency departments (EDs), intensive care units (ICUs), and even prehospital settings. Its superior imaging capability during cardiopulmonary resuscitation (CPR) supports rapid diagnosis, optimization of compression quality, and more accurate rhythm assessment, including the differentiation between asystole and fine ventricular fibrillation. TEE has been shown to influence intra-arrest clinical decision-making in up to 78% of cases, often revealing pathologies-such as aortic dissection or cardiac rupture-not detected by TTE. Importantly, TEE aids in identifying reversible causes of cardiac arrest, guiding high-quality CPR by assessing left ventricular outflow tract (LVOT) obstruction, and shortening the duration of pulse checks. It also may play a role in extracorporeal CPR (ECPR) and organ donation procedures, particularly in cannulation and monitoring during extracorporeal membrane oxygenation (ECMO) and normothermic regional perfusion (NRP). TEE use is feasible and safe during cardiac arrest, with high insertion success rates and minimal complications when performed by trained personnel. While cardiologists, anesthesiologists, and intensivists traditionally perform TEE, simplified training protocols now enable emergency physicians to safely and effectively deploy TEE in critical settings. Protocols such as "POCUS-TEE" may promote rapid acquisition of essential views, facilitating broader implementation. Despite the potential benefits, several barriers to widespread adoption remain. These include the availability of equipment, limitations in training, and concerns regarding the safety of the probe during defibrillation. Resuscitation guidelines recommend removing the transesophageal echocardiogram (TEE) probe, or at least insulating it, as a precaution during defibrillation. TEE is particularly valuable when TTE proves inadequate, such as in obese or mechanically ventilated patients. In conclusion, TEE might enhance the quality and precision of resuscitation in cardiac arrest and has the potential to improve survival and neurological outcomes in selected cases. Its broader adoption hinges on institutional support, streamlined protocols, operator training, and further research to validate its impact on patient-centered outcomes. As technology advances and clinical integration improves, TEE may become a cornerstone of advanced life support in both in-hospital and out-of-hospital settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.